2023 - Research.com Medicine in France Leader Award
2023 - Research.com Microbiology in France Leader Award
2022 - Research.com Microbiology in France Leader Award
The scientist’s investigation covers issues in Hepatitis B virus, Virology, Hepatitis B, Immunology and Internal medicine. His Hepatitis B virus research is classified as research in Virus. His Virology study frequently links to other fields, such as Molecular biology.
Fabien Zoulim has included themes like Nucleoside analogue, Viral load, Liver disease and Entecavir, Lamivudine in his Hepatitis B study. The various areas that Fabien Zoulim examines in his Immunology study include Liver cancer, Hepatocellular carcinoma and Drug resistance. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Pegylated interferon and Pathology.
His main research concerns Virology, Hepatitis B virus, Internal medicine, Hepatitis B and Immunology. His research combines Molecular biology and Virology. HBsAg, Hepadnaviridae, HBeAg, Lamivudine and cccDNA are subfields of Hepatitis B virus in which his conducts study.
His studies deal with areas such as Gastroenterology and Ribavirin as well as Internal medicine. His biological study spans a wide range of topics, including Nucleoside analogue, Viral hepatitis, Hepatitis, Liver disease and Entecavir. His research on Immunology often connects related areas such as Drug resistance.
Fabien Zoulim mainly investigates Hepatitis B virus, Internal medicine, Virology, Gastroenterology and Hepatitis B. His Hepatitis B virus research includes themes of Coinfection, Genome and Viral replication. His Internal medicine study combines topics in areas such as HBsAg and Hepatitis C virus.
Carcinogenesis is closely connected to Genotype in his research, which is encompassed under the umbrella topic of Virology. His work in Gastroenterology addresses issues such as Hepatitis C, which are connected to fields such as Sofosbuvir and Antibody. Hepatitis B is a primary field of his research addressed under Immunology.
Hepatitis B virus, Internal medicine, Hepatitis B, Cirrhosis and Gastroenterology are his primary areas of study. His study on Hepatitis B virus is covered under Virology. His research investigates the connection between Internal medicine and topics such as HBsAg that intersect with problems in Clinical trial, Cmax, Loading dose and Area under the curve.
Hepatitis B is a subfield of Immunology that Fabien Zoulim tackles. Fabien Zoulim interconnects Liver transplantation, CD8 and Myocardial infarction in the investigation of issues within Cirrhosis. His Gastroenterology research incorporates themes from Pharmacokinetics, Hepatitis C, Cmin and Hepatitis C virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti.
Journal of Hepatology (2017)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban.
Journal of Hepatology (2009)
A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness
Lieven Stuyver;Sija De Gendt;Caroline Van Geyt;Fabien Zoulim.
Journal of General Virology (2000)
Persistence of cccDNA During the Natural History of Chronic Hepatitis B and Decline During Adefovir Dipivoxil Therapy
Bettina Werle-Lapostolle;Scott Bowden;Stephen Locarnini;Karsten Wursthorn;Karsten Wursthorn.
Gastroenterology (2004)
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia.
Journal of Hepatology (2008)
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Lars Petter Jordheim;David Durantel;Fabien Zoulim;Charles Dumontet.
Nature Reviews Drug Discovery (2013)
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
Hepatology (2007)
Hepatitis B virus resistance to nucleos(t)ide analogues.
Fabien Zoulim;Fabien Zoulim;Stephen Locarnini.
Gastroenterology (2009)
Woodchuck hepatitis virus X protein is required for viral infection in vivo.
F Zoulim;J Saputelli;C Seeger.
Journal of Virology (1994)
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890
Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey.
Journal of Hepatology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Inserm
Hospices Civils de Lyon
Grenoble Alpes University
Université Paris Cité
Federal University of Toulouse Midi-Pyrénées
University Hospital of Nancy
Université Paris Cité
Université Paris Cité
Inserm
Université Paris Cité
University of Warwick
Aalto University
University of Waterloo
University of Auckland
Baylor College of Medicine
Centre for Addiction and Mental Health
Norwegian Polar Institute
Masaryk University
Yale University
Wake Forest University
The University of Texas Health Science Center at Houston
University of Dundee
Stellenbosch University
University of Massachusetts Amherst
University of Maryland, College Park
University of California, Los Angeles